Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a Locations section with Texas as a study site, expanding where the trial is recruiting. The footer revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedMinor textual updates to the Publications section clarify that PubMed entries are automatically filled and may not all be related to the study. The page revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe banner containing the government funding operating-status disclaimer was removed from the page. The study details and related information remain unchanged.SummaryDifference0.4%

- Check62 days agoChange DetectedThe study results have been posted to the study record (Results First Posted 2025-07-31). This update adds results-related information and references to publications.SummaryDifference0.4%

- Check91 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference3%

- Check98 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.